Verified Nov 2026
Other
·

Cambridge, Massachusetts
·
Since 1980
Sarepta Therapeutics is a biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts, with 500 to 1,000 employees and estimated revenue of $1 billion to $5 billion. It develops precision genetic medicines for rare genetic diseases, particularly Duchenne muscular dystrophy, and operates facilities in Massachusetts and North Dakota. The company has four FDA-approved DMD therapies, including Elevidys, the first approved gene therapy for the disorder, and maintains a pipeline targeting neuromuscular diseases.
Sarepta Therapeutics at a glance
Revenue
$1-5B
Est. band
Employees
500-1,000
Founded
1980
Headquarters
Cambridge, Massachusetts
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Overview
Sarepta Therapeutics is a biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts, with 500 to 1,000 employees and estimated revenue of $1 billion to $5 billion. It develops precision genetic medicines for rare genetic diseases, particularly Duchenne muscular dystrophy, and operates facilities in Massachusetts and North Dakota. The company has four FDA-approved DMD therapies, including Elevidys, the first approved gene therapy for the disorder, and maintains a pipeline targeting neuromuscular diseases.
At a glance
Attribute | Detail |
|---|---|
Founded | 1980 |
Headquarters | Cambridge, Massachusetts |
Employees | 500-1,000 |
Revenue | $1-5B (estimated) |
What Sarepta Therapeutics makes
The company operates a fully integrated platform encompassing drug discovery, development, manufacturing, and commercialization for genetic therapies and is advancing RNA-based treatments for conditions including myotonic dystrophy type 1.
Latest developments
2026-11-05 — Sarepta Therapeutics Announces Third Quarter 2026 Financial Results and Recent Corporate Developments | Sarepta Therapeutics, Inc. (sarepta.com)
2026-03-25 — Sarepta sees early success with RNAi drugs from Arrowhead | BioPharma Dive (biopharmadive.com)
2026-02-25 — Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments | Sarepta Therapeutics, Inc. (sarepta.com)
2026-02-24 — Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan (wedbush.com)
2025-11-24 — Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1 | Sarepta Therapeutics, Inc. (sarepta.com)
2025-08-13 — Sarepta Therapeutics Announces Advancement of siRNA Collaboration and Sale of Arrowhead Equity Investment | Sarepta Therapeutics, Inc. (sarepta.com)
Facilities
Sarepta Therapeutics is headquartered in Cambridge, Massachusetts. Public sources also reference these locations:
Massachusetts — sarepta.com
Fargo, North Dakota — sarepta.com
Company details
Sarepta maintains a global presence with offices across Europe and Brazil and serves patients through disease-specific clinical trial programs and patient advocacy initiatives. Sarepta Therapeutics was founded in 1980, has an estimated 500-1,000 employees, and is headquartered in Cambridge, Massachusetts.
Frequently asked questions
What does Sarepta Therapeutics do?
Sarepta Therapeutics is a biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts, with 500 to 1,000 employees and estimated revenue of $1 billion to $5 billion. It develops precision genetic medicines for rare genetic diseases, particularly Duchenne muscular dystrophy, and operates facilities in Massachusetts and North Dakota. The company has four FDA-approved DMD therapies, including Elevidys, the first approved gene therapy for the disorder, and maintains a pipeline targeting neuromuscular diseases.
Where is Sarepta Therapeutics headquartered?
Sarepta Therapeutics is headquartered in Cambridge, Massachusetts (215 First Street, Cambridge, Massachusetts, 02142).
When was Sarepta Therapeutics founded?
Sarepta Therapeutics was founded in 1980.
How big is Sarepta Therapeutics?
Sarepta Therapeutics has an estimated 500-1,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
